6 completed, 1 terminated, 1 withdrawn. 5 Phase 1, 2 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Terminated 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 4 | 1 | Completed 1 |
Follow AC-1202: new trials by email Literature Review of AC-1202 trials Research Report on AC-1202
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tricaprilin Liquid Formulation PK Study AC-1202, AC-OLE-01, AC-OLE-02 - Alzheimer Disease | Phase 1 | Terminated | Cerecin | 71 | 2021-08-31 | 2023-10-17 |
| Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production Tricaprilin, Placebo - Alzheimer Disease | Phase 1 | Completed | Cerecin | 32 | 2019-08-30 | 2020-07-08 |
| Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides MCTprocal medical food, Milk/tricaprilin oil blend, AC-1207 - Alzheimer Disease | Phase 1 | Withdrawn | Cerecin | 2019-02-13 | 2018-09-27 | |
| Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production AC-1202, AC-SD-01 (50 g), AC-SD-01 (75 g) - Healthy | Phase 1 | Completed | Cerecin | 17 | 2017-03-11 | 2017-06-27 |
| Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production Caprylic Triglyceride Oil, AC-1202, Axona - Healthy | Phase 1 | Completed | Cerecin | 20 | 2016-07-01 | 2017-04-11 |
| A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease caprylidene, Placebo - Alzheimer Disease | Phase 4 | Completed | University of California, Los Angeles | 17 | 2010-10-01 | 2015-03-23 |
| Tricaprilin In Age-Associated Memory Impairment Tricaprilin, Placebo - Age-Associated Memory Impairment | Phase 2 | Completed | Cerecin | 156 | 2006-07-01 | 2020-09-18 |
| Tricaprilin in Mild to Moderate Alzheimer's Disease Tricaprilin, Placebo - Alzheimer's Disease | Phase 2 | Completed | Cerecin | 152 | 2004-11-04 | 2020-09-21 |
Alzheimer Disease (5) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Dementia (1) · Ketosis (1)
Cerecin (7) · University of California, Los Angeles (1)
United States (5) · Australia (2)
Cathy Lee, PhD (1) · Charles Tomek, MD (1) · Colleen Hunsaker, D.O. (1) · Dan Silverman, MD, PhD (1) · Ellen Woo, PhD (1) · Jeffrey Cummings, MD (1) · John Ringman, MD (1) · Joshua Grill, PhD (1) · Maryam Beigi, MD (1) · Samuel Henderson, PhD (1) · Thomas Hochadel, Pharm.D. (1)